Cinnamon: Benefits, Dosage, Contraindications

Updated on

Cinnamon is prepared from an evergreen tree (cinnamon tree) that grows in regions of Southeast Asia. The bark is the used part. It is harvested during the rainy season. Cinnamon is a plant known in Chinese medicine for thousands of years, where it is used as a treatment for diabetes. In ancient Egypt, it was used as a flavoring for drinks. Today, two main species of cinnamon are cultivated, Cinnamomum verum, also known as Ceylon cinnamon, and Cinnamomum cassia, also known as Chinese cinnamon. Both forms of cinnamon contain an essential oil composed mainly of cinnamaldehyde (up to 80% in C. verum and 90% in C. cassia) and mainly differ in their eugenol and coumarin content. Traditionally, cinnamon is used to stimulate appetite and relieve digestive problems and various bacterial infections. In conjunction with a suitable diet, it is used in cases of metabolic syndrome and early-stage type 2 diabetes.

Other name(s) 

a:0:{}

Scientific name(s)

Cinnamomum verum

Family or group: 

Plants

Active ingredients:

Proanthocyanidins

Polyphenols


Indications

Rating methodology

EFSA approval.

Several clinical trials (> 2) randomized controlled with double blind, including a significant number of patients (>100) with consistently positive outcomes for the indication.
Several clinical trials (> 2) randomized controlled with double blind, and including a significant number of patients (>100) with positive outcomes for the indication.
One or more randomized studies or multiple cohorts or epidemiological studies with positive outcomes for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or contradictory.
Lack of clinical studies to date that can demonstrate the indication.


Type 2 Diabetes
✪✪✪✪✪

Some clinical studies of cinnamon in diabetic patients have found significant benefits, while others have not confirmed these benefits. The best evidence comes from a meta-analysis of these clinical trials, which included 543 adults with type 2 diabetes. The results show that taking 120 mg to 6 grams of cassia cinnamon per day for 4 to 18 weeks reduces fasting blood glucose levels by an average of 25 mg/dL, total cholesterol by 16 mg/dL, low-density lipoprotein (LDL) cholesterol by 9 mg/dL, and triglycerides by 30 mg/dL, and increases high-density lipoprotein (HDL) cholesterol by 2 mg/dL. Conversely, cinnamon has no effect on glycated hemoglobin (HbA1c), although many studies were too short to detect a significant change. The studies were also small and highly heterogeneous concerning dose, duration, use of conventional medications, and baseline diabetes control. It seems that the duration of use, dosage, and baseline glycemic levels could be important factors influencing outcomes and deserve further study. Additionally, effects on type 2 diabetes are more promising than on type 1 diabetes. In patients with type 1 diabetes, clinical research shows that daily cinnamon intake does not improve fasting blood glucose, HbA1c, insulin sensitivity, or the frequency of hypoglycemic episodes. Another factor is the type of cinnamon used, as many different species are available in products, and they may differ in their chemical composition and resulting activities. For example, some studies have used water-soluble cinnamon extract, rather than the whole spice. Unfortunately, some studies do not specify which cinnamon was used, making study interpretation difficult. Finally, the use of antidiabetic medications in conjunction with cinnamon may yield better results. An early successful study conducted in patients taking sulfonylureas (a drug that increases insulin secretion) showed significant effects on fasting blood glucose. Indeed, increased insulin secretion, combined with cinnamon's role in reducing insulin resistance, could lead to better results.

Posologie

posologieOral: bark

posologie120 - 6000 mg

duration12 - weeks

formulationpowder, dry extract


Digestive Disorders
✪✪✪✪✪

The essential oil of cinnamon bark and ground cinnamon bark are used in the treatment of dyspeptic conditions, such as mild spasmodic states of the gastrointestinal tract, fullness, and flatulence, loss of appetite, and diarrhea. Although controlled studies are not available, evidence of antispasmodic activity in animal models and a long tradition of use provide some support for its use in these indications. Cinnamon bark and Chinese cinnamon are approved by the German Commission E for the treatment of loss of appetite and dyspeptic complaints such as mild gastrointestinal spasms, bloating, and flatulence. The ESCOP indicates that cinnamon is used in dyspeptic conditions such as gastrointestinal spasms, bloating and flatulence, loss of appetite, diarrhea...

Posologie

posologieOral: bark

posologie500 - 1500 mg

formulationpowder, essential oil, dry extract


Metabolic Syndrome
✪✪✪✪✪

The results on the effectiveness of Cinnamon among pre-diabetics are contradictory. A small clinical study conducted on patients with glucose intolerance shows that taking 6 g of cinnamon powder (C. cassia) twice a day for 12 weeks does not improve fasting blood glucose or insulin sensitivity compared to placebo. However, a water-soluble cinnamon extract (Cinnulin PF 500 mg/day) significantly reduced fasting blood glucose and systolic blood pressure and increased lean body mass, according to a placebo-controlled trial conducted on 22 subjects with pre-diabetes and metabolic syndrome. The study was conducted over 12 weeks and also detected slight but statistically significant decreases in body fat in the cinnamon-treated group when intra-group analyses were performed. Another clinical study conducted on overweight or obese patients with impaired fasting glucose shows that taking a dried aqueous extract of cassia cinnamon 250 mg twice per day for 12 weeks reduces fasting blood glucose by approximately 12 mg/dL from baseline, but does not affect fasting insulin levels. Another preliminary clinical trial conducted on overweight or obese patients with glucose intolerance shows that daily intake of two capsules of a specific product (Glycabiane, PiLeJe) containing 228 mg of cassia cinnamon extract, 10 mcg of chromium chloride, and 100 mg of carnosine per capsule, for 4 months, reduces fasting blood glucose by 6.5 mg/dL but has no effect on glycated hemoglobin (HbA1c), insulin sensitivity, or body weight, compared to placebo.

Posologie

posologieOral: bark

posologie500 mg

formulationpowder, dry extract


Synergies


Gestational Diabetes
✪✪✪✪✪

A randomized, double-blind, placebo-controlled study conducted on 51 women with gestational diabetes revealed that 6 weeks of treatment with 1g of cinnamon per day resulted in a trend towards reducing insulin needs (53.85% for cinnamon vs. 44% for placebo); however, this trend was not significant. The cinnamon used was C. cassia. Researchers suggested that a longer treatment duration might be necessary to achieve better results.

Posologie

posologieOral: bark

posologie1000 mg

formulationpowder, dry extract


Dysmenorrhea
✪✪✪✪✪

Cinnamon has been traditionally used for gynecological problems in women such as dysmenorrhea, menorrhagia, lactation, and labor pains. A small study demonstrated that using cinnamon (Cinnamomum Zeylancium) at a dose of 3g per day can significantly reduce the intensity of menstrual pain.

Posologie

posologieOral: bark

posologie3000 mg

formulationpowder


Bacterial Infections
✪✪✪✪

Cinnamon has been traditionally used for common infections like bronchial, ENT, urinary or gastrointestinal infections. In TCM, it is considered to warm the kidneys and fortify yang, and is therefore used for impotence, among other indications.

Posologie

posologieOral: bark

posologie1500 mg

formulationpowder, essential oil, dry extract


Cough
✪✪✪✪

Cinnamon has numerous applications in traditional medicine. It has been used against cough, abdominal cramps, and intestinal spasms.

Posologie

posologieOral: bark

posologie1500 mg

formulationpowder, essential oil, dry extract


Warts
✪✪✪✪

Cinnamon essential oil, rich in cinnamaldehyde, is traditionally used to treat warts, thanks to its dermocaustic properties that act directly on the lesion. Use pure or diluted in vegetable oil.

Posologie

posologieTopical: bark

posologie3 drops

formulationessential oil


Properties


Antibacterial

full-leaffull-leaffull-leafempty-leaf

Several in vitro studies have identified broad-spectrum antibacterial and antifungal effects for both species of cinnamon. These effects have been mainly attributed to cinnamaldehyde, although other constituents such as eugenol, caryophyllene, and 1,8-cineole also exhibit antimicrobial properties. The C. verum species has shown activity against a wide range of bacteria and fungi, including Bacillus subtilis, Escherichia coli, Saccharomyces cerevisiae, Candida albicans, Listeria monocytogenes, and Salmonella enterica. Cinnamon extracts have proven superior to two other antifungals (garlic and calendula) in an in vitro study and have been recommended as an effective herbal treatment for candidiasis. In vitro, cinnamon extracts significantly inhibit Helicobacter pylori with an effect equal to or greater than commonly used antibiotics. Similarly, cinnamon bark essential oil allows for the in vitro inhibition of pathogenic respiratory strains (S. pneumoniae, S. pyogenes, S. aureus, H. influenzae, etc.).

Usages associés

Bacterial infections

Hypoglycemic

full-leaffull-leaffull-leafempty-leaf

Type A and B procyanidin oligomers present in various extracts of Cinnamon cassia have been identified as having hypoglycemic activity and can improve insulin sensitivity in the treatment of rats with induced type 2 diabetes. Polyphenolic polymers such as hydroxychalcone found in cassia cinnamon seem to potentiate the action of insulin. These compounds appear to increase the phosphorylation of the insulin receptor, thereby enhancing insulin sensitivity. Increased insulin sensitivity can improve blood glucose control and lipid levels. Cinnamon extracts also seem to activate glycogen synthase and increase glucose uptake. Research on animals and in vitro suggests that cassia cinnamon has a more significant insulin-stimulating effect than Ceylon cinnamon. Research conducted in healthy humans shows that cassia cinnamon improves blood glucose control and insulin sensitivity in the short term; however, clinical trials on diabetic patients have yielded conflicting results.

Usages associés

Type 2 diabetes, Metabolic syndrome, Gestational diabetes

Digestive Effect

full-leaffull-leafempty-leafempty-leaf

Cinnamon is traditionally used to aid digestion and as a carminative in association with other plants, in cases of flatulence, bloating, mild gastrointestinal spasms, and as an appetite stimulant.

Usages associés

Digestive disorders

Antifungal

full-leaffull-leafempty-leafempty-leaf

The bark of Cinnamomum cassia has demonstrated a strong antifungal activity against strains of Candida albicans. Among the different extracts tested, the chloroform extract proved to be the most effective, with inhibition zones reaching up to 60 mm and minimum inhibitory concentrations (MICs) of 0.10 µg/ml for Candida albicans ATCC 10231. These results even surpass those of amphotericin B, a reference antifungal. The bioactive compounds identified in the bark include terpenes, flavonoids, and alkaloids, which are responsible for these remarkable antifungal effects.


Uricosuric Effect

full-leafempty-leafempty-leafempty-leaf

Cinnamon bark extract has been studied in combination with Chrysanthemum indicum flower extract. The combination reduced serum uric acid levels in rats and promotes uric acid excretion in urine. This association also inhibits xanthine oxidase activity, hepatic uric acid production, and cellular uric acid uptake in vitro.


Cardiovascular

full-leafempty-leafempty-leafempty-leaf

Data from animal experiments suggest that cinnamon might have a beneficial effect on lipid metabolism control. Animal studies have shown that treatment with a water-soluble cinnamon extract induces a decrease in blood glucose and postprandial serum triglycerides.

Usages associés

Metabolic syndrome


Safety dosage

Adult from 18 years: 500 mg - 4000 mg

- infusion: 2 to 4 g of Ceylon cinnamon bark for 1 cup of boiling water, infuse 10 minutes, drink 2 to 3 times a day - dried bark: 1.5 to 4 g per day - powder 0.5 to 1.5 g per day; - essential oil: 0.005 to 0.2 g per day; - fluid extract (1:1 at 70% alcohol) 2-4 ml


Interactions

Médicaments

Anti-diabetic: weak interaction

Cassia cinnamon may lower blood glucose levels and have additive effects in patients treated with anti-diabetic agents. Adjustments to diabetes medication dosages might be necessary.

Antiplatelets/Anticoagulant: weak interaction

In vitro, cinnamaldehyde, a principal compound of Cinnamoni Cortex, inhibits the release of arachidonic acid and therefore the formation of thromboxane B2. It can thus reduce platelet aggregation. Theoretically, the concomitant use of C.cassia with anticoagulants/antiplatelet agents could increase the risk of bleeding.


Precautions

Liver disorders: avoid

Coumarins taken orally in high doses are known to cause liver damage in rodents and similar isolated incidents of hepatotoxicity have been observed in humans. C. cassia contains high amounts of coumarin (up to 87,000 mg/kg) compared to C. verum or C. burmannii. Warning from several European health agencies regarding the consumption of large amounts of cassia, due to its high coumarin content. Hepatotoxic doses of coumarin in therapy: 50-7000 mg/day. (tolerable daily intake of coumarins from food: 0-0.1mg/kg body weight) The French agency recommends not exceeding 0.1mg/kg/day of essential oil (i.e., 3g of Chinese cinnamon).

Lactating women: avoid

There is not enough reliable information available about the safety of cassia cinnamon when used in medicinal amounts during breastfeeding.

Children up to 18 years: use with caution

Half the dose compared to adults.


Contraindications

Pregnant women: prohibited

C. cassia or C. zeylanicum/verum should not be used during pregnancy; however, usual dietary intakes are likely safe. Currently, evidence of teratogenicity from animal studies is contradictory.